News

Boosting the immune system's T cells to effectively attack solid tumors can be achieved by adding a small molecule to an immunotherapeutic strategy known as chimeric antigen receptor-T (CAR-T) cell therapy.

A comprehensive study conducted by Uppsala University researchers, involving more than 250,000 women, demonstrates that oral contraceptives protect against ovarian and endometrial cancer.

Scientists have discovered a way to inhibit tumor cells from repairing their own DNA, which could be used in new therapeutic treatments of disease.

Scientists have developed a promising new approach for treating lymphomas, cancers that begin in infection-fighting cells of the immune system called lymphocytes.

Scientists have developed a new method that allows for the easier construction of proteins, using RNA molecules to read genes.

A research team has identified a type of immune cell that acts as a major driver of breast cancer growth by preventing the accumulation of a specific protein that induces anti-tumor effects.

Esophageal adenocarcinoma is occurring more frequently in adults under 50 years of age, and these younger adults are more likely to be diagnosed at advanced stages, according to a new study.

A new study investigated two genes associated with breast cancer development in women, and found that mutations of these vary on other risk factors in the human genome.

Researchers have discovered that inhibition of a certain protein in metastasizing cancers may result in the suppression of tumor formations.

Pioneering new research has made a pivotal breakthrough that dispels concerns that human stem cells could contain cancer-causing mutations.